CNTA vs UTHR · $6.15B cap vs P/E 20, rev $1.56B
Centessa Pharmaceuticals PLC ADR (CNTA) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
CNTA currently screens at market cap $6.15B. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the CNTA and UTHR stock pages for the full models.
Not investment advice.